Ilsung Is Co., Ltd.

₩20,800As of Sun 8 Nov 2026, 12:00 UTC
KRX:003120Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 4.10%
Div yield 7.21%
ROE 1.47%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.21)
PE TTM 26.43
TSR TTM (4.49%)
Mkt cap ₩145.0B
ROIC (2.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩25,394
22.09%
6.56%
Hold 8|1|11|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
546.59
589.32
568.83
558.89
32.43%
33.82%
16.65%
5.04%
Revenue₩B
16.19
16.51
17.26
17.48
2.97%
1.44%
5.12%
8.56%
Peers (US$106.9M)
Cap (US$)
PE
106.3M
3.616x
105.2M
7.897x
Capital
TTM
5Y
10Y
Leveragex
1.851
0.030
0.026
EBIT/Intx
0.884
0.061
0.061
Own earn%
(268.63)
48.90
58.55
Sh yield%
44.46
49.45
48.81
Owners
Insiders/Inst%
3.60
85.60
Short interest%
4.44
SBC / revenue%
1.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
27–32
$1 testx
0.0
Incr. ROIC%
52